Form 4/A for NRXP NRX Pharmaceuticals, Inc.

Accepted 2022-12-19 00:00:00 ET · period of report 2022-11-25 · accession 0001415889-22-012650 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MA	2022-12-19	2022-11-25	NRXP	VAN VOORHEES SETH	CFO	P - Purchase	$1.11	+16.3K	16.3K	New	+$18.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.001 per share	2022-11-25	P	A	600	$1.10	9,316	D	—	—	(F2) The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
2	Common	Common Stock, par value $0.001 per share	2022-11-25	P	A	8,716	$1.12	8,716	D	—	—	(F1) The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.
3	Common	Common Stock, par value $0.001 per share	2022-11-25	P	A	7,021	$1.11	16,337	D	—	—	(F3) Total number of shares held is reduced by 40 shares to correct an arithmetic error in the original Form 4. (F4) The form of ownership has been changed from Indirect to Direct. The original Form 4 stated that these shares were purchased though a 401(k) plan. This Form 4/A is being filed to correct this error.